Cargando…

Effect of 12-Week Daily Intake of the High-Lycopene Tomato (Solanum Lycopersicum), a Variety Named “PR-7”, on Lipid Metabolism: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

Tomato (Solanum lycopersicum) is a rich source of lycopene, a carotenoid that confers various positive biological effects such as improved lipid metabolism. Here, we conducted a randomized, double-blind, placebo-controlled, parallel-group comparative study to investigate the effects of regular and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Mie, Tominaga, Naoki, Ishikawa-Takano, Yuko, Maeda-Yamamoto, Mari, Nishihira, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566250/
https://www.ncbi.nlm.nih.gov/pubmed/31130668
http://dx.doi.org/10.3390/nu11051177
_version_ 1783426810754629632
author Nishimura, Mie
Tominaga, Naoki
Ishikawa-Takano, Yuko
Maeda-Yamamoto, Mari
Nishihira, Jun
author_facet Nishimura, Mie
Tominaga, Naoki
Ishikawa-Takano, Yuko
Maeda-Yamamoto, Mari
Nishihira, Jun
author_sort Nishimura, Mie
collection PubMed
description Tomato (Solanum lycopersicum) is a rich source of lycopene, a carotenoid that confers various positive biological effects such as improved lipid metabolism. Here, we conducted a randomized, double-blind, placebo-controlled, parallel-group comparative study to investigate the effects of regular and continuous intake of a new high-lycopene tomato, a variety named PR-7, for 12 weeks, based on 74 healthy Japanese subjects with low-density lipoprotein cholesterol (LDL-C) levels ≥120 to <160 mg/dL. The subjects were randomly assigned to either the high-lycopene tomato or placebo (lycopene-free tomato) group. Each subject in the high-lycopene group ingested 50 g of semidried PR-7 (lycopene, 22.0–27.8 mg/day) each day for 12 weeks, while subjects in the placebo group ingested placebo semidried tomato. Medical interviews were conducted, vital signs were monitored, body composition was determined, and blood and saliva samples were taken at weeks 0 (baseline), 4, 8, and 12. The primary outcome assessed was LDL-C. The intake of high-lycopene tomato increased lycopene levels in this group compared to levels in the placebo group (p < 0.001). In addition, high-lycopene tomato intake improved LDL-C (p = 0.027). The intake of high-lycopene tomato, PR-7, reduced LDL-C and was confirmed to be safe.
format Online
Article
Text
id pubmed-6566250
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65662502019-06-17 Effect of 12-Week Daily Intake of the High-Lycopene Tomato (Solanum Lycopersicum), a Variety Named “PR-7”, on Lipid Metabolism: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Nishimura, Mie Tominaga, Naoki Ishikawa-Takano, Yuko Maeda-Yamamoto, Mari Nishihira, Jun Nutrients Article Tomato (Solanum lycopersicum) is a rich source of lycopene, a carotenoid that confers various positive biological effects such as improved lipid metabolism. Here, we conducted a randomized, double-blind, placebo-controlled, parallel-group comparative study to investigate the effects of regular and continuous intake of a new high-lycopene tomato, a variety named PR-7, for 12 weeks, based on 74 healthy Japanese subjects with low-density lipoprotein cholesterol (LDL-C) levels ≥120 to <160 mg/dL. The subjects were randomly assigned to either the high-lycopene tomato or placebo (lycopene-free tomato) group. Each subject in the high-lycopene group ingested 50 g of semidried PR-7 (lycopene, 22.0–27.8 mg/day) each day for 12 weeks, while subjects in the placebo group ingested placebo semidried tomato. Medical interviews were conducted, vital signs were monitored, body composition was determined, and blood and saliva samples were taken at weeks 0 (baseline), 4, 8, and 12. The primary outcome assessed was LDL-C. The intake of high-lycopene tomato increased lycopene levels in this group compared to levels in the placebo group (p < 0.001). In addition, high-lycopene tomato intake improved LDL-C (p = 0.027). The intake of high-lycopene tomato, PR-7, reduced LDL-C and was confirmed to be safe. MDPI 2019-05-25 /pmc/articles/PMC6566250/ /pubmed/31130668 http://dx.doi.org/10.3390/nu11051177 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nishimura, Mie
Tominaga, Naoki
Ishikawa-Takano, Yuko
Maeda-Yamamoto, Mari
Nishihira, Jun
Effect of 12-Week Daily Intake of the High-Lycopene Tomato (Solanum Lycopersicum), a Variety Named “PR-7”, on Lipid Metabolism: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
title Effect of 12-Week Daily Intake of the High-Lycopene Tomato (Solanum Lycopersicum), a Variety Named “PR-7”, on Lipid Metabolism: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
title_full Effect of 12-Week Daily Intake of the High-Lycopene Tomato (Solanum Lycopersicum), a Variety Named “PR-7”, on Lipid Metabolism: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
title_fullStr Effect of 12-Week Daily Intake of the High-Lycopene Tomato (Solanum Lycopersicum), a Variety Named “PR-7”, on Lipid Metabolism: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
title_full_unstemmed Effect of 12-Week Daily Intake of the High-Lycopene Tomato (Solanum Lycopersicum), a Variety Named “PR-7”, on Lipid Metabolism: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
title_short Effect of 12-Week Daily Intake of the High-Lycopene Tomato (Solanum Lycopersicum), a Variety Named “PR-7”, on Lipid Metabolism: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
title_sort effect of 12-week daily intake of the high-lycopene tomato (solanum lycopersicum), a variety named “pr-7”, on lipid metabolism: a randomized, double-blind, placebo-controlled, parallel-group study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566250/
https://www.ncbi.nlm.nih.gov/pubmed/31130668
http://dx.doi.org/10.3390/nu11051177
work_keys_str_mv AT nishimuramie effectof12weekdailyintakeofthehighlycopenetomatosolanumlycopersicumavarietynamedpr7onlipidmetabolismarandomizeddoubleblindplacebocontrolledparallelgroupstudy
AT tominaganaoki effectof12weekdailyintakeofthehighlycopenetomatosolanumlycopersicumavarietynamedpr7onlipidmetabolismarandomizeddoubleblindplacebocontrolledparallelgroupstudy
AT ishikawatakanoyuko effectof12weekdailyintakeofthehighlycopenetomatosolanumlycopersicumavarietynamedpr7onlipidmetabolismarandomizeddoubleblindplacebocontrolledparallelgroupstudy
AT maedayamamotomari effectof12weekdailyintakeofthehighlycopenetomatosolanumlycopersicumavarietynamedpr7onlipidmetabolismarandomizeddoubleblindplacebocontrolledparallelgroupstudy
AT nishihirajun effectof12weekdailyintakeofthehighlycopenetomatosolanumlycopersicumavarietynamedpr7onlipidmetabolismarandomizeddoubleblindplacebocontrolledparallelgroupstudy